BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca ...

Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...

Biodesix, Inc. has announced that new research will be showcased at upcoming conferences, including the ISPOR 2025 Annual Meeting in Montreal and the ATS 2025 International Conference in San Francisco ...

Dr. J. Nicholas Bodor of Fox Chase Cancer Center explains possible risk factors, symptoms to watch for, and the importance of ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

{Dr. Nilanju Sarmah, Head R&D and Academics, Metropolis Healthcare Limited} Lung cancer is the leading cause of ...

Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20, 2025 /PRNewswire/ -- For people with lung cancer, ...

Select your location to view local American Lung Association events and news near you.

CNW/ - One in five Albertans live with a lung condition, yet access to critical testing is limited in many rural and remote communities. This lack of ...